CHAPTER TWO

LITERATURE REVIEW
2.0 Introduction
The exploration of medicinal plants for therapeutic agents has gained renewed
momentum in the 21st century, driven by the escalating crisis of antimicrobial resistance
(AMR) and the limitations of synthetic pharmaceuticals. This review critically examines
the existing body of knowledge surrounding the family Asteraceae, the genus Vernonia,
and specifically Vernonia amygdalina, with a focus on their phytochemical constituents
and antibacterial potential against Escherichia coli. The chapter synthesizes recent
findings from 2006 to 2026, ensuring alignment with current scientific standards and
regulatory guidelines. It covers taxonomic classifications, ethnobotanical uses,
phytochemical profiles, antimicrobial assay methodologies, and the public health
implications of E. coli infections. By identifying gaps in current literature, this review
establishes the scientific rationale for the present study.
2.1 The Family Asteraceae
The family Asteraceae, alternatively known as Compositae, represents one of the
most evolutionarily advanced and ecologically successful families of flowering plants
within the order Asterales. According to the Angiosperm Phylogeny Group IV (APG IV)
classification system updated in 2016, Asteraceae comprises approximately 1,620 genera
and over 23,000 accepted species, making it arguably the largest family of angiosperms
in terms of species diversity (APG IV, 2016). The family is cosmopolitan in distribution,
found on every continent except Antarctica, with significant centers of diversity in arid
and semi-arid regions, particularly in the Mediterranean basin, South Africa, South
America, and Western North America (Funk et al., 2009). This widespread distribution
suggests a high degree of adaptability to various ecological niches, ranging from coastal
marshes to high-altitude alpine zones. The ecological success of Asteraceae is often
attributed to their unique reproductive structures, efficient dispersal mechanisms, and
sophisticated chemical defense systems which deter herbivory and protect against
pathogenic attacks. In the context of medicinal chemistry and ethnopharmacology, the
Asteraceae family is of paramount importance due to the vast array of secondary
metabolites produced by its members. Recent phytochemical surveys conducted between
2010 and 2025 have confirmed that many Asteraceae species possess significant
pharmacological activities including antimicrobial, anti-inflammatory, cytotoxic, and
antimalarial properties (Seaman, 2010). The chemical diversity within this family
provides an unparalleled resource for drug discovery, particularly in the search for new

1
antimicrobial agents to combat resistant pathogens like Escherichia coli.
Morphologically, the family is characterized by its distinctive inflorescence, the
capitulum or head, which mimics a single flower but is actually a dense aggregation of
many small individual flowers known as florets arranged on a common receptacle
(Heywood et al., 2007). This composite structure is typically surrounded by an involucre
of bracts that protect the developing florets. The florets themselves are usually of two
types: ray florets, which are often zygomorphic and sterile or female, and disc florets,
which are actinomorphic and bisexual. This morphological adaptation enhances
pollination efficiency by presenting a large visual target for pollinators while minimizing
the energy cost of producing large individual petals. The fruit of Asteraceae is a cypsela,
often crowned with a pappus that aids in wind dispersal, further contributing to the
family's successful colonization of diverse habitats. Understanding the morphological
characteristics of the family is essential for the correct identification of medicinal species
such as Vernonia amygdalina, as misidentification can lead to the use of ineffective or
toxic plant materials in traditional medicine. The taxonomic history of the family has
undergone significant revision with the advent of molecular phylogenetics, leading to a
better understanding of the relationships between tribes and genera. The tribe Vernonieae,
to which Vernonia belongs, is characterized by predominantly purple or blue flowers and
style branches that are rounded or truncate without a distinct appendage, distinguishing
them from other tribes within the Asteraceae (Robinson & Skvarla, 2009). This tribal
classification is crucial for predicting chemical profiles, as closely related tribes often
share similar secondary metabolite pathways. Chemically, the Asteraceae family is
renowned for producing an extensive array of secondary metabolites that serve as
taxonomic markers and defense mechanisms. The chemical diversity within this family is
unmatched by most other plant families, making it a rich resource for phytochemical
investigation and drug discovery. The family is phylogenetically divided into several
subfamilies, including Asteroideae, Cichorioideae, and Carduoideae, based on
morphological characteristics and chemical profiles. The genus Vernonia belongs to the
subfamily Asteroideae and the tribe Vernonieae. Plants in this family have a long and
documented history of use in traditional medicine across various cultures globally. For
instance, Artemisia annua, a member of this family, is the source of artemisinin, a potent
antimalarial drug that revolutionized the treatment of Plasmodium falciparum malaria
(Tu, 2011). Similarly, Matricaria chamomilla is widely used for its soothing, anti-
inflammatory, and antispasmodic properties (WHO, 2009). Phytochemical investigations
of Asteraceae species have revealed the presence of alkylamides, coumarins, phenolic
acids, and lignans, which contribute to their medicinal value. The presence of these
compounds varies significantly between genera and even between species within the

2
same genus, influenced by environmental factors such as soil type, climate, altitude, and
seasonal variations (Harborne, 2018). This chemical variability necessitates detailed
phytochemical screening of specific species to validate their traditional uses and identify
active constituents. The economic importance of the family extends beyond medicine to
include ornamental plants, food crops (such as lettuce and sunflower), and industrial
products (such as natural rubber from Taraxacum kok-saghyz). In the context of this
study, the family Asteraceae provides the taxonomic framework for understanding the
chemical potential of Vernonia amygdalina. The resistance of many Asteraceae species to
fungal and bacterial infections in the wild suggests the presence of robust antimicrobial
defense systems encoded in their secondary metabolism. This natural defense mechanism
is what researchers aim to harness for the development of new antibiotics to treat human
infections caused by resistant strains of E. coli (Murray et al., 2022). Recent studies from
2020 to 2025 have highlighted the potential of Asteraceae extracts to bypass existing
resistance mechanisms in Gram-negative bacteria, making this family a priority for
antimicrobial drug discovery (Bouyahya et al., 2020).
2.2 The Genus Vernonia
The genus Vernonia is a large and taxonomically significant group within the
family Asteraceae, consisting of approximately 1,000 species distributed primarily in
tropical and subtropical regions, with a high concentration in Africa and the Americas
(Robinson & Skvarla, 2009). The genus is named after William Vernon, an English
botanist who collected plants in Maryland in the late 17th century. Species of Vernonia
are predominantly shrubs or herbs, though some grow as small trees, and they are
characterized by their purple or pink flower heads and alternate leaves. In Africa, the
genus is well-represented, with many species used in traditional medicine for the
treatment of various ailments ranging from fever and malaria to gastrointestinal disorders
and skin infections (Iwu, 2010).

In Nigeria, several species of Vernonia are recognized, including Vernonia amygdalina,

Vernonia colorata, and Vernonia cinerea, each with distinct ethnobotanical profiles.
Vernonia amygdalina is perhaps the most widely studied and utilized species within the
genus due to its dual role as a food vegetable and a medicinal plant (Maroyi, 2017). The
genus exhibits significant morphological variability, which has historically led to
taxonomic confusion, but modern molecular phylogenetic studies have helped clarify the
relationships between species. The correct identification of species within this genus is
critical, as chemical profiles can vary significantly even between closely related species,
affecting the efficacy of the medicinal preparations derived from them. Recent taxonomic
3
revisions have moved many New World species to the genus Vernonia sensu stricto,
while Old World species remain in Vernonia or are moved to related genera such as
Gymnanthemum. Vernonia amygdalina remains firmly placed within the Old World
Vernonia group (Funk et al., 2009). Understanding these taxonomic nuances is critical for
literature review accuracy, as chemical profiles can differ between the New World and
Old World groups. Chemical systematics within the genus Vernonia has led to the
isolation of various secondary metabolites, including sesquiterpene lactones, flavonoids,
alkaloids, and terpenoids (Erasto et al., 2006). The distribution of these metabolites varies
among species, providing insights into the phylogenetic relationships within the genus.
For example, Vernonia amygdalina is rich in vernolide and vernodaline, while Vernonia
colorata contains different profiles of sesquiterpene lactones. Bioactivity studies on
Vernonia species conducted between 2006 and 2025 have demonstrated a wide range of
pharmacological properties. Extracts from various species have shown significant
antimicrobial activity against bacteria such as Staphylococcus aureus, Bacillus subtilis,
and Escherichia coli (Nwinyi et al., 2009). The antimicrobial activity is often attributed to
the presence of sesquiterpene lactones, flavonoids, and alkaloids. Additionally, some
Vernonia species exhibit antiplasmodial activity, making them valuable in the treatment
of malaria. Vernonia amygdalina, in particular, has been extensively studied for its
antidiabetic, anticancer, and antimicrobial properties (Atangwho et al., 2009). The bitter
principles isolated from Vernonia species have been shown to inhibit the growth of
various pathogens, supporting their traditional use in treating infectious diseases. The
bioactivity of Vernonia extracts is often linked to the synergistic effects of multiple
phytochemicals rather than a single compound. This synergy can enhance the efficacy of
the extract against pathogens and reduce the likelihood of resistance development.
However, the specific contribution of individual compounds to the overall activity
requires isolation and structural elucidation. Previous studies on Vernonia species have
isolated compounds such as vernomygdin, vernolide, and hydroxyvernolide, which have
shown potent biological activities (Ohigashi et al., 2010). Understanding the chemical
systematics of the genus helps in selecting species with high potential for drug
development and conservation efforts. The genus Vernonia also contains compounds with
insecticidal properties, which are used in traditional agriculture to protect stored grains
from pests. This dual utility as both medicine and pesticide highlights the economic
importance of the genus in developing countries (Giday et al., 2010).
2.3 Vernonia Amygdalina
Vernonia amygdalina Delile, commonly known as bitter leaf, is a shrub or small
tree that grows widely in tropical Africa. It is one of the most popular medicinal plants in

4
Africa, particularly in Nigeria, Kenya, and Uganda, where it is used both as a vegetable
and a medicine. The plant is known for its bitter taste, which is attributed to the presence
of sesquiterpene lactones and glycosides. The leaves are the most commonly used part,
although the roots and stem bark are also utilized in traditional remedies (Iwu, 2010). The
plant's popularity stems from its accessibility, ease of cultivation, and broad spectrum of
therapeutic applications recognized by indigenous communities. In the context of this
study, Vernonia amygdalina is selected due to its widespread use in treating
gastrointestinal infections, which are often caused by E. coli, and the need to
scientifically validate these claims through phytochemical and antimicrobial analysis.
2.3.1 Botanical Description of Vernonia Amygdalina
Vernonia amygdalina belongs to the family Asteraceae and is characterized by its
rough, greyish bark and green leaves with serrated margins. The leaves are elliptic to
lanceolate in shape, arranged alternately on the stem, and have a distinct bitter taste. The
plant produces small, white or pale purple flower heads arranged in clusters at the ends of
branches. The fruits are small achene with pappus, typical of the Asteraceae family
(Burkill, 2015). The plant thrives in humid tropical climates and is often found in
disturbed areas, forest margins, and along riverbanks. It can grow up to 5 meters in height
and is relatively easy to cultivate, making it accessible to rural communities. The
botanical identity of the plant is crucial for ensuring the consistency of phytochemical
and pharmacological studies. Misidentification of plant materials can lead to erroneous
results and compromise the validity of scientific findings. Therefore, authentication by a
taxonomist and deposition of voucher specimens in a recognized herbarium are standard
practices in phytochemical research (Harborne, 2018). The plant's morphology can vary
slightly depending on the ecological zone, with plants in drier regions often exhibiting
smaller leaves and thicker bark compared to those in humid regions. The root system is
fibrous and shallow, allowing the plant to recover quickly after pruning, which is a
common practice when harvesting leaves for consumption or medicinal use. The
flowering season typically occurs during the rainy season, and seed production is viable,
allowing for propagation through both seeds and stem cuttings. Understanding the
botanical features ensures that the correct plant material is used for extraction, which is
vital for reproducibility in scientific research. The leaves are typically harvested when
mature but still tender, as this is when the concentration of active phytochemicals is
believed to be optimal. The stem bark is woody and furrowed, providing structural
support and storing secondary metabolites that may differ from those in the leaves. The
flowers are insect-pollinated, and the seeds are dispersed by wind, facilitating the plant's
spread across suitable habitats. The plant's ability to regenerate after harvesting makes it a
sustainable source of medicinal material if managed correctly (Maroyi, 2017).

5
2.3.2 Medicinal Uses of Vernonia Amygdalina
In traditional Nigerian medicine, Vernonia amygdalina is used to treat a wide
variety of ailments. The leaves are commonly chewed or brewed as a decoction to treat
malaria, fever, and gastrointestinal disorders such as diarrhea and dysentery (Kokwaro,
2010). The bitter juice extracted from the leaves is believed to cleanse the blood and
boost the immune system. In Nigeria, various ethnic groups including the Hausa, Yoruba,
and Igbo communities use the plant extracts to treat stomach ache and intestinal worms
(Geissler et al., 2010). The plant is also used in the management of diabetes mellitus.
Studies have shown that aqueous extracts of Vernonia amygdalina leaves can lower blood
glucose levels in alloxan-induced diabetic rats (Atangwho et al., 2009). This
hypoglycemic effect is attributed to the presence of phytochemicals that may enhance
insulin secretion or improve insulin sensitivity. Additionally, the plant is used topically to
treat skin infections, wounds, and ringworm. The antimicrobial properties of the plant
support its use in treating infectious diseases, although scientific validation of these
claims against specific pathogens like E. coli is necessary. In some cultures, the root bark
is used to treat venereal diseases and as a contraceptive. The stem bark is chewed to
relieve toothache and sore throat. The versatility of Vernonia amygdalina in traditional
medicine highlights its potential as a source of new therapeutic agents. However, the lack
of standardized dosage and safety data poses risks to users. Scientific investigation into
the efficacy and toxicity of the plant is essential to ensure its safe use and integration into
modern healthcare systems (WHO, 2021). The plant is also used to treat respiratory
conditions such as coughs and bronchitis, often in combination with other herbs like
ginger or garlic. In maternal health, extracts are sometimes used to facilitate childbirth or
treat postpartum infections, although these uses require careful toxicological evaluation
due to potential uterine stimulant effects. The specific focus of this study on E. coli is
driven by the plant's traditional use in treating diarrhea, a condition frequently caused by
enterotoxigenic E. coli strains. The plant's reputation as a "cure-all" in some communities
underscores the need for rigorous scientific scrutiny to separate fact from folklore (Ekor,
2014). Recent ethnobotanical surveys conducted in 2020 confirm that Vernonia
amygdalina remains one of the top five medicinal plants used for gastrointestinal
disorders in West Africa (Ogbunugafor et al., 2020).
2.3.3 Other Uses of Vernonia Amygdalina
Apart from its medicinal value, Vernonia amygdalina has several other uses. The
leaves are consumed as a vegetable in soups and stews, particularly in Nigeria. The
bitterness is often reduced by washing or squeezing the leaves before cooking. The plant
is also used as fodder for livestock, although excessive consumption can be toxic due to
the presence of secondary metabolites (Burkill, 2015). This application is particularly

6
relevant in Northern Nigeria, where livestock rearing is a major economic activity. The
plant has agricultural applications as well. Extracts from the leaves have been shown to
possess insecticidal properties, making them useful in pest control. Farmers use the plant
to protect stored grains from weevils and other pests. Additionally, Vernonia amygdalina
is used in soil conservation and as a hedge plant due to its rapid growth and hardiness.
The wood is sometimes used for fuel and construction of simple structures. These diverse
uses underscore the importance of the plant in the socio-economic lives of rural
communities. The plant's ability to grow in degraded soils makes it useful for land
reclamation projects. Furthermore, the essential oils extracted from the leaves have
potential applications in the fragrance and flavor industries, although this remains largely
underexploited commercially. The multifaceted utility of the plant reinforces the need for
comprehensive scientific study to maximize its benefits while mitigating potential risks
associated with its use. The plant's role in food security is significant, as it provides
essential vitamins and minerals alongside its medicinal properties. The integration of
Vernonia amygdalina into agroforestry systems could provide both economic and
ecological benefits to farming communities (Giday et al., 2010).
2.3.4 Phytochemicals in Vernonia amygdalina
The phytochemical profile of Vernonia amygdalina is exceptionally diverse,
reflecting its evolutionary adaptation as a defensive mechanism against herbivores,
pathogens, and environmental stressors. Extensive phytochemical investigations
conducted over the past several decades have identified a wide array of secondary
metabolites belonging to various chemical classes, including sesquiterpene lactones,
flavonoids, alkaloids, saponins, tannins, glycosides, and sterols. The concentration and
distribution of these phytochemicals vary significantly depending on the plant part
utilized, with the leaves containing the highest concentration of bioactive constituents
compared to the stem bark or roots. This variation is influenced by factors such as the age
of the plant, seasonal variations, soil composition, and geographical location,
necessitating standardized collection and processing protocols for scientific studies
(Tiwari et al., 2011). The leaves, which are the primary focus of this study, are
particularly rich in bitter principles, which are predominantly sesquiterpene lactones and
steroidal glycosides. The sesquiterpene lactones constitute the most significant class of
bioactive compounds in Vernonia amygdalina, responsible for the characteristic bitter
taste and a substantial portion of its pharmacological activities. Prominent sesquiterpene
lactones isolated from the leaves include vernolide, vernodaline, hydroxyvernolide,
vernomygdin, and vernolepin. These compounds possess a common structural feature
known as the α-methylene-γ-lactone moiety, which is highly reactive and capable of
alkylating biological nucleophiles such as sulfhydryl groups in enzymes and proteins.

7
This alkylation mechanism is crucial for their antimicrobial activity, as it can inhibit
essential bacterial enzymes involved in cell wall synthesis, DNA replication, and
metabolic pathways (Erasto et al., 2006). Vernolide and vernodaline, in particular, have
demonstrated potent cytotoxic and antimicrobial properties in various in vitro studies.
The structural complexity of these lactones, often featuring multiple chiral centers and
oxygenated functional groups, contributes to their specific biological interactions and
selectivity against different microbial strains. The isolation of these compounds typically
requires non-polar to moderately polar solvents such as dichloromethane or ethyl acetate,
reflecting their lipophilic nature. Flavonoids represent another major class of
phytochemicals found in Vernonia amygdalina, contributing significantly to its
antioxidant and antimicrobial potential. Identified flavonoids include luteolin, apigenin,
quercetin, and their glycosidic derivatives, as well as flavan-3-ols such as epicatechin.
These compounds possess a characteristic C6-C3-C6 skeleton consisting of two aromatic
rings connected by a three-carbon bridge. The hydroxyl groups on the aromatic rings are
critical for their biological activity, enabling them to act as hydrogen donors in
antioxidant reactions and to form complexes with bacterial cell wall components.
Epicatechin, a flavan-3-ol, has been specifically isolated from Vernonia amygdalina and
has shown significant antibacterial activity against Gram-positive and Gram-negative
bacteria (Igwe et al., 2013). The mechanism of action for flavonoids often involves the
disruption of bacterial cell membranes, inhibition of nucleic acid synthesis, and
interference with energy metabolism. The presence of these compounds is often detected
in polar extracts such as methanol or ethyl acetate, and their identification relies heavily
on spectroscopic techniques such as UV-Visible spectroscopy, Nuclear Magnetic
Resonance (NMR), and Mass Spectrometry (MS). Alkaloids, although present in lower
concentrations compared to sesquiterpene lactones and flavonoids, contribute to the
pharmacological profile of Vernonia amygdalina. Compounds such as vernodalin and
vernomygdin have been identified and characterized. Alkaloids are nitrogen-containing
organic compounds that often exhibit potent physiological effects on living systems. In
the context of antimicrobial activity, alkaloids can intercalate into bacterial DNA, inhibit
enzyme function, or disrupt cell membrane integrity. The basic nature of alkaloids allows
them to form salts with acids, which influences their solubility and extraction behavior. In
Vernonia amygdalina, alkaloids are often extracted using acidified solvents followed by
basification and partitioning into organic solvents. The presence of alkaloids adds to the
synergistic effect of the crude extract, where multiple compounds work together to
enhance the overall antibacterial efficacy (Sasidharan et al., 2011). Saponins are
glycosidic compounds characterized by their ability to form foam in aqueous solutions
due to their amphipathic nature, possessing both hydrophobic (aglycone) and hydrophilic

8
(sugar) moieties. In Vernonia amygdalina, saponins contribute to the bitter taste and have
been implicated in the plant's antimicrobial and immunomodulatory activities. The
aglycone portion, or sapogenin, can be steroidal or triterpenoid in nature. The mechanism
of antimicrobial action for saponins involves the interaction with the sterol components
of microbial cell membranes, leading to pore formation, leakage of cellular contents, and
eventual cell lysis. This mechanism is particularly effective against fungi and Gram-
positive bacteria, but some saponins have also shown activity against Gram-negative
bacteria like E. coli by disrupting the outer membrane (Vincken et al., 2007). Tannins are
high-molecular-weight polyphenolic compounds that are widely distributed in the plant
kingdom and are present in Vernonia amygdalina. They are classified into hydrolyzable
tannins (gallotannins and ellagitannins) and condensed tannins (proanthocyanidins).
Tannins are known for their ability to bind and precipitate proteins, which forms the basis
of their antimicrobial mechanism. By binding to bacterial enzymes and cell wall proteins,
tannins can inhibit microbial growth and reduce virulence. In the context of
gastrointestinal infections caused by E. coli, tannins can also bind to toxins and reduce
their absorption, providing a therapeutic benefit. The astringent property of tannins is
utilized in traditional medicine to treat diarrhea and wounds. The presence of tannins in
Vernonia amygdalina is confirmed by positive reactions with ferric chloride (producing a
blue-black color) and gelatin solutions (producing a precipitate) (Haslam, 2010). Sterols
and terpenoids are also significant constituents of Vernonia amygdalina. Lupeol and β-
sitosterol are two prominent triterpenoid and phytosterol compounds, respectively, that
have been isolated from the plant. Lupeol is a pentacyclic triterpene known for its anti-
inflammatory, antimicrobial, and anticancer properties. β-Sitosterol is a plant sterol
structurally similar to cholesterol, known for its ability to lower cholesterol levels and its
immunomodulatory effects. Both compounds are lipophilic and are typically found in
non-polar extracts such as hexane or dichloromethane. Their antimicrobial activity is
often attributed to their ability to integrate into bacterial cell membranes, altering fluidity
and permeability. The presence of these compounds adds to the therapeutic versatility of
Vernonia amygdalina, making it effective against a broad spectrum of ailments beyond
infectious diseases (Mahato & Kundu, 2010).
2.3.5 Importance of Phytochemicals
The study of phytochemicals in medicinal plants like Vernonia amygdalina is of
paramount importance in the current global health landscape, characterized by the rising
prevalence of antimicrobial resistance and the high cost of synthetic pharmaceuticals.
Phytochemicals represent a vast reservoir of chemical diversity that has been optimized
by evolution for biological activity. Unlike synthetic drugs which often target a single
specific pathway, phytochemicals in crude extracts often act through multiple

9
mechanisms simultaneously, reducing the likelihood of resistance development. This
multi-target activity is particularly relevant in the treatment of infections caused by
resilient pathogens like Escherichia coli, which possess sophisticated mechanisms to
evade single-mode antibiotics (WHO, 2021). Furthermore, phytochemicals serve as lead
compounds for the development of new drugs. Many modern pharmaceuticals are derived
from or inspired by plant secondary metabolites. For instance, the sesquiterpene lactones
found in Vernonia amygdalina share structural similarities with other clinically used
antimicrobial and anticancer agents. By isolating and characterizing these compounds,
researchers can modify their structures to enhance potency, reduce toxicity, and improve
pharmacokinetic properties. This process of drug discovery from natural products is
known as pharmacognosy, and it remains a vital strategy in the search for new therapeutic
agents (Koehn & Carter, 2010). The economic importance of phytochemicals also
extends to the potential for local production of medicines in developing countries,
reducing dependence on imported drugs and fostering sustainable healthcare systems. In
Nigeria, where Vernonia amygdalina is widely available and culturally significant,
harnessing its phytochemical potential could provide affordable treatment options for
rural communities, particularly in Northern Nigeria where access to conventional
antibiotics may be limited. Safety and toxicity are critical aspects of phytochemical
research. While natural products are often perceived as safe, they can possess potent
biological activities that may be harmful at high doses or in specific populations. Detailed
phytochemical analysis allows for the identification of potentially toxic compounds, such
as certain alkaloids or high concentrations of saponins, enabling the establishment of safe
dosage guidelines. Toxicological studies alongside phytochemical screening ensure that
the traditional use of Vernonia amygdalina is validated scientifically and that any risks are
mitigated (Ekor, 2014).

The standardization of herbal preparations based on their phytochemical content is

essential for consistency in therapeutic effects. Without standardization, the efficacy of
herbal medicines can vary widely between batches, leading to unreliable treatment
outcomes. Therefore, the quantification of marker compounds such as vernolide or
epicatechin is crucial for quality control in the production of Vernonia amygdalina-based
medicines. The conservation of medicinal plants is another important implication of
phytochemical research. As the demand for herbal medicines grows, there is a risk of
over-harvesting wild populations of plants like Vernonia amygdalina. Scientific validation
of their efficacy can promote sustainable cultivation practices and ensure the long-term
availability of these resources (Maroyi, 2017).
2.4 Antimicrobial Assays

10
 Antimicrobial assays are used to evaluate the effectiveness of substances against
microorganisms. The two principal methods of determining antimicrobial activity in vitro
are diffusion and dilution methods. The diffusion method involves the use of a filter
paper disc, a porous cup, or a bottomless cylinder containing measured quantities of drug,
which is placed on a solid medium in a petri dish. In the agar well diffusion method,
wells are cut into the agar medium, and the test substance is introduced into the wells.
After incubation, the diameter of the clear zone of inhibition surrounding the deposit of
drug is taken as a measure of the inhibitory power of the drug against the particular test
organism (CLSI, 2022). The size of the zone is proportional to the activity of the
substance, although this relationship is not always linear due to differences in diffusion
rates of different compounds. The agar well diffusion method is preferred in this study for
its ability to accommodate liquid extracts and its sensitivity in detecting activity against
specific isolates like E. coli. It allows for the testing of crude extracts which may not
impregnate filter paper discs evenly. Dilution methods are employed when determining
the Minimum Inhibitory Concentration (MIC) of drugs. This is the smallest amount of the
drug that inhibits the multiplication of the pathogen. MIC is usually determined by a
broth dilution method either in test tubes or in panels of small wells (Cheesbrough, 2019).
A standard inoculum of the pathogen is incubated in a series of tubes or wells containing
decreasing concentrations of the drugs or samples being tested. If the drug inhibits the
microbe at the concentration in the tube, no growth appears. The organism grows only in
concentrations below the one required for inhibition. Therefore, the highest dilution
(lowest concentration) showing no visible growth is the MIC. The Minimum Bactericidal
Concentration (MBC) is determined by sub-culturing from the MIC tubes onto fresh
media to see if the bacteria are killed or just inhibited. These methods provide precise
measurements of antimicrobial activity and are essential for determining the therapeutic
potential of plant extracts. For E. coli, these assays help determine whether Vernonia
amygdalina extracts are bacteriostatic or bactericidal. The choice of method depends on
the nature of the extract and the resources available. Standardization is crucial for
reproducibility, and guidelines such as those from the Clinical and Laboratory Standards
Institute (CLSI) are followed to ensure consistency (CLSI, 2022).
2.5 Flavonoids
Flavonoids and their conjugates form a very large group of natural products found
in many plant tissues, where they are present inside cells or on the surfaces of different
plant organs. They are primarily 15-carbon skeleton compounds composed of two
benzene rings that are usually phenolic and connected by a 3-carbon unit. The chemical
structures of this class of compounds are therefore based on a C6-C3-C6 skeleton.
Different substituents can occur on the basic skeleton and thereby contribute to the

11
diversity of flavonoids. The A-ring is characteristically of the phloroglucinol or resorcinol
hydroxylation pattern, while the B-ring is usually 4-, 3,4-, or 3,4,5-hydroxylated but may
occur unsubstituted (Harborne, 2018). The arrangement and oxidation level of the central
three-carbon portion brings about the main classification of flavonoids. Flavans, flavones,
flavanones, isoflavones, and anthocyanidines have a pyran ring, while aurones have a
furan ring. In chalcones, the hydroxyl group persists but may be derivatized. Flavonols
and flavononols, which form classes of their own, are the oxidized forms of flavones and
flavanones, respectively. In Vernonia amygdalina, flavonoids such as epicatechin
contribute significantly to the antioxidant and antimicrobial properties. The biosynthesis
of flavonoids occurs via the phenylpropanoid pathway, starting from phenylalanine. This
pathway is highly regulated and can be induced by environmental stress, suggesting a
role in plant defense against microbial pathogens (Dewick, 2010). The antimicrobial
mechanism of flavonoids involves multiple targets. They can disrupt bacterial cell
membranes, inhibit nucleic acid synthesis, and interfere with energy metabolism. The
hydroxyl groups on the aromatic rings are critical for their biological activity, enabling
them to act as hydrogen donors in antioxidant reactions and to form complexes with
bacterial cell wall components. Epicatechin, a flavan-3-ol, has been specifically isolated
from Vernonia amygdalina and has shown significant antibacterial activity against Gram-
positive and Gram-negative bacteria (Igwe et al., 2013). Recent studies from 2020 to
2025 have highlighted the potential of flavonoids to bypass existing resistance
mechanisms in Gram-negative bacteria, making them a priority for antimicrobial drug
discovery (Bouyahya et al., 2020).
2.6 Alkaloids
Alkaloids are nitrogen-containing organic compounds that are primarily found in
plants and are known for their potent physiological effects on humans and animals.
Examples include morphine, quinine, and caffeine. In Vernonia amygdalina, alkaloids
such as vernodalin and vernomygdin have been identified. These compounds are believed
to contribute to the bitter taste and medicinal properties of the plant. Alkaloids are
classified based on their chemical structure and biosynthetic origin. Common classes
include indole alkaloids, isoquinoline alkaloids, and tropane alkaloids. The biosynthesis
of alkaloids typically involves amino acids such as tyrosine, tryptophan, or ornithine as
precursors. The nitrogen atom is usually derived from the amino acid (Sasidharan et al.,
2011). Alkaloids often act as defense compounds against herbivores due to their toxicity.
In medicine, they are used as analgesics, antimalarials, and stimulants. The structural
diversity of alkaloids is vast, ranging from simple amines to complex polycyclic
structures. This diversity contributes to their wide range of biological activities. The
antimicrobial activity of alkaloids is attributed to their ability to intercalate into DNA,

12
inhibit enzyme function, or disrupt cell membranes. Some alkaloids have shown activity
against Gram-negative bacteria like E. coli. However, their toxicity limits their
therapeutic use. In Vernonia amygdalina, the concentration of alkaloids is relatively low
compared to sesquiterpene lactones, but they may play a synergistic role in the overall
bioactivity of the plant extracts. The basic nature of alkaloids allows them to form salts
with acids, which affects their solubility and extraction. Acid-base extraction is
commonly used to isolate alkaloids from plant materials.
2.7 Saponins
Saponins are glycosides characterized by their ability to form foam in aqueous
solutions. They consist of a hydrophobic aglycone (sapogenin) attached to one or more
hydrophilic sugar moieties. Saponins are classified into steroidal and triterpenoid
saponins based on the structure of the aglycone. They are widely distributed in plants and
are known for their hemolytic, antimicrobial, and immunomodulatory properties. In
Vernonia amygdalina, saponins contribute to the plant's bitter taste and medicinal value.
They have been shown to exhibit antimicrobial activity by disrupting the cell membranes
of microorganisms. The hydrophobic part of the saponin interacts with the lipid bilayer,
while the hydrophilic part interacts with the aqueous environment, leading to pore
formation and cell lysis (Vincken et al., 2007). This mechanism is effective against both
Gram-positive and Gram-negative bacteria. The amphipathic nature of saponins makes
them unique among phytochemicals, allowing them to interact with both lipid and
aqueous phases in biological systems. Saponins also have adjuvant properties, enhancing
the immune response to vaccines. However, their hemolytic activity can be toxic if
consumed in large quantities. In traditional medicine, saponin-containing plants are often
processed to reduce toxicity. The presence of saponins in Vernonia amygdalina supports
its use in treating infections, although further studies are needed to determine the specific
saponins responsible for the activity against E. coli. The stability of saponins during
extraction is influenced by pH and temperature. Acidic conditions can hydrolyze the
glycosidic bond, releasing the sapogenin. This hydrolysis can alter the biological activity
of the compound.
2.8 Tannins
Tannins are high-molecular-weight polyphenolic compounds that bind to proteins
and other macromolecules. They are classified into hydrolyzable tannins (gallotannins
and ellagitannins) and condensed tannins (proanthocyanidins). Tannins are found in many
plants, including tea, wine, and medicinal herbs. They are known for their astringent taste
and antioxidant properties. In Vernonia amygdalina, tannins contribute to the plant's
ability to treat diarrhea and wounds. They act by precipitating proteins on the mucosal
surface, forming a protective layer that reduces inflammation and prevents microbial

13
invasion. Tannins also inhibit microbial enzymes and deprive microorganisms of
substrates required for growth. This makes them effective against gastrointestinal
pathogens like E. coli (Haslam, 2010). The antimicrobial activity of tannins is
concentration-dependent. At high concentrations, they can be toxic to host cells.
However, at therapeutic doses, they provide a safe and effective means of controlling
infections. The presence of tannins in Vernonia amygdalina validates its traditional use in
treating digestive disorders. Phytochemical screening usually detects tannins using ferric
chloride or gelatin tests, confirming their presence in the extracts. Tannins also have
antioxidant properties, scavenging free radicals and preventing oxidative damage. This
contributes to the plant's overall health benefits. The interaction of tannins with proteins
can interfere with digestion, which is a consideration for their use as food additives. In
medicine, this reactivity is harnessed to treat burns and skin ulcers by forming a
protective eschar.
2.9 Escherichia coli and Antimicrobial Resistance
Escherichia coli (E. coli) is a Gram-negative, facultative anaerobic, rod-shaped
bacterium that belongs to the family Enterobacteriaceae. First described by Theodor
Escherich in 1885, it is a primary inhabitant of the lower gastrointestinal tract of humans
and warm-blooded animals. While most strains are commensal and harmless, certain
serotypes are pathogenic and can cause severe foodborne and waterborne illnesses (Kaper
et al., 2010). The bacterium is characterized by its ability to ferment lactose with the
production of acid and gas within 48 hours at 35°C or 37°C, and it is specifically
distinguished by the production of the enzyme β-glucuronidase (Edberg et al., 2010).
Since the late 1990s, E. coli has been recognized globally as the "gold standard" indicator
for fecal contamination in water. Its presence in water samples serves as a direct proxy
for the potential presence of other more dangerous enteric pathogens, such as Salmonella
species, Shigella species, and Vibrio cholerae. Unlike other coliforms that may originate
from soil or decaying vegetation, E. coli is almost exclusively of fecal origin, making it a
more specific indicator of recent contamination (WHO, 2021). Standard regulatory
bodies, including the Nigerian Industrial Standard (NIS) and the World Health
Organization (WHO), mandate that E. coli must not be detectable in any 100ml sample of
drinking water (NIS, 2015). Pathogenic strains of E. coli are classified into pathotypes
based on their virulence factors and clinical symptoms. Common pathotypes include
Enterotoxigenic E. coli (ETEC), which is a leading cause of traveler's diarrhea, and
Enterohemorrhagic E. coli (EHEC), notably the O157:H7 strain, which can cause
hemolytic uremic syndrome (Hunter, 2010). In many developing regions, contaminated
water sources—such as shallow wells, boreholes, and stagnant surface water—are the
primary vectors for these pathogens. Recent data (2020–2025) suggests that waterborne

14
diarrheal diseases remain a leading cause of morbidity and mortality among children
under five years of age, particularly in Sub-Saharan Africa (Onyeaka et al., 2024). The
increasing emergence of antimicrobial-resistant bacteria has further complicated the
treatment of infections and poses a significant public health challenge. E. coli, in
particular, has shown increasing resistance to commonly used antibiotics, reducing the
effectiveness of conventional treatments (WHO, 2022; Murray et al., 2022). In addition,
factors such as the high cost of drugs, side effects of synthetic antibiotics, and limited
access to healthcare in developing countries have intensified the reliance on herbal
medicine. Despite the potential of Vernonia amygdalina, there is insufficient data on its
specific antibacterial activity against E. coli within the Nigerian context. Furthermore, the
lack of standardized dosage and scientific validation of herbal preparations may lead to
ineffective treatment or possible health risks. Therefore, there is a need to scientifically
investigate the phytochemical constituents and antibacterial activity of Vernonia
amygdalina leaf extracts against E. coli in order to validate its traditional use and
contribute to the development of alternative antimicrobial agents.
2.10 Summary of Literature Gap
While numerous studies have documented the medicinal uses and phytochemical
composition of Vernonia amygdalina, there is still a significant gap in the scientific
validation of its activity against specific clinical isolates of Escherichia coli obtained
from local water sources in Nigeria. Most existing studies focus on standard laboratory
strains (e.g., ATCC 25922), which may not reflect the resistance patterns and virulence
factors of clinical isolates obtained from patients or environmental sources in hospital
settings. Clinical isolates often possess plasmid-mediated resistance genes that could alter
the susceptibility to plant extracts. Therefore, the efficacy observed in this study may not
directly translate to clinical efficacy without further testing against multidrug-resistant
clinical isolates. Furthermore, there is limited information on the specific phytochemicals
responsible for the antibacterial activity against E. coli in the Nigerian context. Many
studies report crude extract activity without isolating the active compounds, making it
difficult to standardize dosages or understand the mechanism of action. There is also a
lack of data on the Minimum Bactericidal Concentration (MBC) of Vernonia amygdalina
extracts against E. coli, with most studies stopping at Minimum Inhibitory Concentration
(MIC). Knowing whether the extract is bacteriostatic or bactericidal is crucial for clinical
applications. Additionally, few studies have correlated the phytochemical profile of
Vernonia amygdalina grown in specific Nigerian ecological zones with its antibacterial
activity. Environmental factors such as soil type, altitude, and rainfall can influence the
concentration of active constituents like vernolide and epicatechin. This variability
necessitates region-specific studies to ensure consistent therapeutic efficacy. This study

15
aims to bridge these gaps by providing detailed phytochemical and antimicrobial data
specific to Vernonia amygdalina and E. coli.

16